Citation Impact
Citing Papers
Role of nitric oxide in inflammatory diseases
2007 Standout
Shedding light onto live molecular targets
2003 Standout
Identification of the renal erythropoietin-producing cells using transgenic mice
1993 StandoutNobel
Phantom limb pain
2001 Standout
Neural mechanism underlying acupuncture analgesia
2008 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Dynamics of skin blood flow in human sepsis
1995
Clinical Efficacy and Safety of Recombinant Canine Erythropoietin in Dogs with Anemia of Chronic Renal Failure and Dogs with Recombinant Human Erythropoietin-Induced Red Cell Aplasia
2004
Microvascular changes in chronic venous insufficiency—a review
1995
Vascular function in systemic sclerosis
2000
Vascular Endothelial Growth Factor Augments Muscle Blood Flow and Function in a Rabbit Model of Chronic Hindlimb Ischemia
1996
Sites of erythropoietin production
1997 StandoutNobel
A brief review on the history of human functional near-infrared spectroscopy (fNIRS) development and fields of application
2012 Standout
Raynaud's phenomenon
2001
Diffuse optics for tissue monitoring and tomography
2010
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin
2004
The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression
1997 StandoutNobel
Morphologic Study of Microcirculation in Acromegaly by Capillaroscopy1
1999
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
1994 StandoutNobel
Molecular biology of erythropoietin
1993 StandoutNobel
Diabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
2006 Standout
Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
1989
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
1998 Standout
The Role of Oxygen in Cutaneous Photodynamic Therapy
1998
Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells
1998
A review on continuous wave functional near-infrared spectroscopy and imaging instrumentation and methodology
2013 Standout
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Is acupuncture effective for the treatment of chronic pain? A systematic review
2000
Organ distribution of erythropoietin messenger RNA in normal and uremic rats
1991 StandoutNobel
Skin Melanin, Hemoglobin, and Light Scattering Properties can be Quantitatively Assessed In Vivo Using Diffuse Reflectance Spectroscopy
2001
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
Microvascular Blood Flow Is Altered in Patients with Sepsis
2002 Standout
Clinical Efficacy and Safety of Recombinant Canine Erythropoietin in Dogs with Anemia of Chronic Renal Failure and Dogs with Recombinant Human Erythropoietin‐Induced Red Cell Aplasia
2004
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
2018 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Skin Microcirculation of the Foot in Diabetic Neuropathy
1996
Determination of amputation level in ischaemic limbs using tcPO2 measurement
2005
Acupuncture: Theory, Efficacy, and Practice
2002 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Nonpharmacologic Therapies for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline
2007 Standout
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
1996
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Microvascular Changes in Venous Disease: An Update
1997
Investigation of Chronic Venous Insufficiency
2000 Standout
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Vascular endothelial growth factor (VEGF) and its receptors
1999 Standout
Works of L Caspary being referenced
Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture
1997
Comparison of Laser-Doppler-Flux and tcPO2 in Healthy Probands and Patients with Arterial Ischemia
1987
Fast Wavelength Scanning Reflectance Spectrophotometer for Noninvasive Determination of Hemoglobin Oxygenation in Human Skin
1994
Quantitative Reflection Spectrophotometry: Spatial and Temporal Variation of Hb Oxygenation in Human Skin
1995
Effect of Treatment with Recombinant Human Erythropoietin on Peripheral Hemodynamics and Oxygenation
2015
Transcutaneous oxygen pressure measured at two different electrode core temperatures in healthy volunteers and patients with arterial occlusive disease.
1987
[Transcutaneous oxygen measurement and laser Doppler flowmetry in patients with arterial occlusive disease, chronic venous insufficiency and a combination of both diseases].
1987
Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus.
1991
Biological zero in laser Doppler fluxmetry.
1988
Nailfold capillaroscopy and laser Doppler fluxmetry for evaluation of Raynaud's phenomenon: how valid is the local cooling test?
1997
Disturbances of skin microcirculation in patients with chronic arterial occlusive disease and venous incompetence.
1988
Prostanoids in therapy of peripheral arterial occlusive disease.
1992
Intermittent intra-arterial prostaglandin E1 therapy of severe claudication.
1987